Physician profile
Justin T Albright
NPI 1942480314
$6,261.82
in general payments reported to CMS, 2019-2025
15 companies · $2,165 in 2025
The $2,165 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $881 · 2020: $334 · 2021: $315 · 2022: $377 · 2023: $856 · 2024: $1,333 · 2025: $2,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,614 · Food and Beverage: $1,741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,614.01 |
| Food and Beverage | $1,740.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,496.69 | 2024-2025 | |
| Paragon 28, INC. | $994.62 | 2019-2021 | |
| P Bar Medical LLC | $967.77 | 2025 | |
| Pylant Medical | $761.43 | 2020-2024 | |
| Stryker Corporation | $680.06 | 2019-2024 | Actishield, Iconix, Prostep Mica |
| Becton, Dickinson and Company | $588.35 | 2023 | Venclose Maven Catheter |
| Abbott Laboratories | $178.76 | 2025 | Esprit |
| Depuy Synthes Sales INC. | $158.70 | 2022-2025 | Fibergraft Bg Morsels, N/A, Motoband Cp |
| Horizon Therapeutics Plc | $131.04 | 2023 | Krystexxa |
| Treace Medical Concepts, INC. | $111.24 | 2025 | |
| Organogenesis INC. | $65.19 | 2021-2023 | Puraply |
| Nalu Medical, INC. | $41.29 | 2025 | Nalu Neurostimulation System |
| Encore Medical, LP | $40.46 | 2021 | |
| Smith+Nephew, INC. | $28.30 | 2023 | Collagenase Santyl |
| Averitas Pharma INC. | $17.92 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Albright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.